Award recordCONTRACT

GRIFOLS THERAPEUTICS LLC

PIID VA24413F4115· VHA· 503-ALTOONA· 6505 · DRUGS AND BIOLOGICALS· FY2014· $37,405 net obligations· UEI UFQ3A7GKJ5C7· NC

Description

DRUGS

First action · last action
2013-10-01 · 2014-10-22
Transactions
3
First transaction's obligation
$34,800
Base + all options value (sum of deltas)
$37,405
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30042
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$37,800$0Base award · 2013-10-01 · this action $34,800 · running total $34,800Modification P00001 · 2014-09-03 · this action $3,000 · running total $37,800Modification P00002 · 2014-10-22 · this action -$395 · running total $37,405
  • Base2013-10-01+$34,800= $34,800
  • Mod P000012014-09-03+$3,000= $37,800
  • Mod P000022014-10-22-$395= $37,405
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-10-01+$34,800$34,800DRUGS
Mod P00001· FUNDING ONLY ACTION2014-09-03+$3,000$37,800DRUGS
Mod P00002· FUNDING ONLY ACTION2014-10-22−$395$37,405DRUGS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UFQ3A7GKJ5C7)

AwardOffice · PSC / listingNet obligationsFY
36C26022F0140260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$100,282FY2022
36C26022F0004260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$454,461FY2022
36C26021F0264260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$130,406FY2021
36C26021F0117260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$75,000FY2021
36C26021F0014260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$220,000FY2021
36C26021F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$355,273FY2021

Other recipients under 6505 from 503-ALTOONA (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24414F4202FISHER SCIENTIFIC COMPANY L.L.C.503-ALTOONA$9,542FY2014
VA24413P2434ASD SPECIALTY HEALTHCARE, LLC503-ALTOONA$13,162FY2013
VA24413P1170ASD SPECIALTY HEALTHCARE, LLC503-ALTOONA$13,020FY2013
VA24413F3114TALECRIS BIOTHERAPEUTICS HOLDINGS CORP.503-ALTOONA$37,360FY2013
VA24412P2702MCKESSON CORPORATION503-ALTOONA$8,424FY2012

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24413F4115_3600_V797D30042_3600 · retrieved 2026-09-26.